References

Abbas, A.K., A.H. Lichtman, and J.S. Pober. 1998. In Cellular and Molecular Immunology, 3rd edition. WB Saunders Company, Harcourt Brace and Co, USA.

Adams, D.O. and T.A. Hamilton. 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:283-318.

Ahvazi, B.C., P. Jacobs and M.M. Stevenson. 1995. Role of macrophage­derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria. J. Leukoc. Biol. 58:23-31.

Albert, M.L., B. Sauter and N. Bhardwaj. 1998a. Dendritic cells acquire antigen from apoptotic cells and induce class !-restricted CTLs. Nature. 392:86-89.

Albert, M.L., S.F. Pearce, L.M. Francisco, B. Sauter, P. Roy, R.L. Silverstein and N. Bhardwaj. 1998b. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359-1368.

Albina, J.E. 1995. On the expression of nitric oxide synthase by human macrophages. Why no NO? J. Leukoc. Biol. 58:643-649.

Allavena, P., F. Peccatori, D. Maggioni, A. Erroi, M. Sironi, N. Colombo, A. Lissoni, A. Galazka, W. Meiers and C. Mangioni. 1990. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor­associated effectors and of major histocompatibility antigen expression on tumor cells. Cancer Res. 50:7318-7323.

Al-Sarireh, B. and 0. Eremin. 2000. Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J.R. Coli. Surg. Edinb. 45:1-16.

Andreesen, R., J. Osterholz, H. Bodemann, K.J. Bross, U. Costabel and G.W. Lohr. 1984. Expression of transferrin receptors and intracellular ferritin during terminal differentiation of human monocytes. Blut. 49:195-202.

Andreesen R., W. Brugger, C. Scheibenbogen, M. Kreutz, H.G. Leser, A. Rehm and G.W. Lohr. 1990. Surface phenotype analysis ofhuman monocyte to macrophage maturation. J. Leukoc. Biol. 47: 490-497.

Arase, H., N. Arase and T. Saito. 1996. Interferon-y production by natural killer (NK) cells and NKl.ll T cells upon NKR-Pl cross-linking. J. Exp. Med. 183:2391-2396.

113

References

Arenzana Seisdedos, F., J.L. Virelizier and W. Fiers. 1985. Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin-1 secretory potential of fresh or aged human monocytes. J. Immunol. 134:2444-2448.

Arteaga, C.L., S.D. Hurd, A.R. Winnier, M.D. Johnson, B.M. Fendly and J.T. Forbes. 1993. Anti-Transforming Growth Factor (TGF)-f3 Antibodies Inhibit Breast Cancer Cell Tumorigenicity and Increase Mouse Spleen Natural Killer Cell Activity. J. Clin. Invest. 92:2569-2576.

Austyn, J.M., J.W. Kupiec-Weglinski, D.F. Hankins and P.J. Morris. 1988. Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone. J. Exp. Med. 167:646-651. ·

Austyn, J.M. 1996. New insights into the mobilization and phagocytic activity of dendritic cells. J. Exp. Med. 183:1287-1292.

Baeuerle, P.A. and T. Henkel. 1994. Function and activation of NF-KB in the immune system. Annu. Rev. Immunol. 12:41-179.

Baggiolini, M., B. Dewald and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675-705.

Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature. 392:565-568.

Balkwill, F.R. 1988. Cytokines- Soluble factors in immune responses. Curr. Opin. Immunol. 1:241-249.

Balkwill, F.R. and F. Burke. 1989. The cytokine network. Immunol. Today. 10:299-304.

Baloch, Z., S. Cohen and F.D. Coffman. 1990. Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II. J. Immunol. 145:2908-2913.

Banchereau, J. and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.

Banks, T.A., B.T. Rouse, M.K~ Kerley, P.J. Blair, V.L. Godfrey, N.A. Kuklin, D.M. Bouley, J. Thomas, S. Kanangat and M.L. Mucenski. 1995. Lymphotoxin-alpha-deficient mice. Effect on secondary lymphoid organ development and humoral immune responsiveness J. Immunol. 155:1685-1693.

Bastian, N.R. and J.B. Hibbs, Jr~ 1994. Assembly and regulation of NADPH oxidase and nitric oxide synthase. Curr. Opin. Immunol. 6:131-139.

114

References

Baeuerle, P.A. and T. Henkel. 1994. Function and activation ofNF-kappa Bin the immune system. Annu. Rev. Immunol. 12:141-179.

Beckman, J.S. and W.H. Koppenol. 1996. Nitric oxide, superoxide and peroxynitrite: The good, the bad, and ugly. Am. J. Physiol. 271:C1424-C1437.

Bellingan, G.J., H. Caldwell, S.E. Howie, I. Dransfield and C. Haslett. 1996. In vivo fate of the inflammatory macrophage during resolution of inflammation: Inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J. Immunol. 157:2577-2585.

Bellone, M., G. Iezzi, P. Rovere, G. Galati, A. Ronchetti, M.P. Protti, J. Davoust, C. Rugarli and A.A. Manfredi. 1997. Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159:5391-5399.

Bhaumik, S. and A. Khar. 1998a. Cytokine-induced production of NO by macrophages induces apoptosis and immunological rejection of AK-5 histiocytic tumor. Apoptosis 3:361-368.

Bhaumik, S. and A. Khar. 1998b. Induction of nitric oxide production by the peritoneal macrophages after intraperitoneal or subcutaneous transplantation of AK-5 tumor. Nitric Oxide. 2:467-474.

Bloom, E.T. and J.A. Horvath. 1994. Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity: Implications for the age-related decline in CTL. J. Immunol. 152:4242-4254.

Boehm, U., T. Klamp, M. Groot and J.C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.

Bottazzi, B., N. Polentarutti, R. Acero, A. Balsari, D. Boraschi, P. Ghezzi, M. Salmona and A. Mantovani. 1983. Regulation of the macrophage content of neoplasms by chemoattractants. Science. 220:210-212.

Bradley, L.M., D.K. Dalton and M. Croft. 1996. A direct role for IFN-y in regulation ofTh1 cell development. J. Immunol. 157:1350-1358.

Brenan, M. and D.J. Rees. 2000. Sequence analysis or rat integrin alphaE 1 and alphaE2 subunits: tissue expression reveals phenotypic similarities between intraepithelial lymphocytes and dendritic cells in lymph. Eur. J. Immunol. 30:1527-1537.

Broche, F. and J.M. Tellado. 2001. Defense mechanisms of the peritoneal cavity. Curr. Opin. Crti. Care. 7:105-116.

115

References

Brown, E.J. 1994. Phagocytosis. BioEssays. 187:109-117.

Brugger, W., M. Kreutz and R. Andreesen. 1991. Macrophage colony­stimulating factor is required for human monocyte survival and acts as a cofactor for their terminal differentiation to macrophages in vitro. J. Leukoc. Biol. 49:483-488.

Brunda, M.J. and M.K. Gately. 1994. Antitumor activity of interleukin-12. Clin. Immunol. Immunopathol. 71:253-255.

Butcher, E.C. and L.J. Picker. 1996. Lymphocyte homing and homeostasis. Science. 272:60-66.

Car, B.D., V.M. Eng, B. Schnyder, M. LeHir, A.N. Shakhov, G. Woerly, S. Huang, M. Aguet, T.D. Anderson and B. Ryffel. 1995. Role of interferon-yin interleukin-12-induced pathology in mice. Am. J. Pathol. 147:1693-1707.

Carcelain, G., N. Rouas-Freiss, E. Zorn, V. Chung-Scott, S. Viel, F. Faure, J. Bosq and T. Hercend. 1997. In situ T-cell responses in a primary regressive melanoma and subsequent metastases: a comparative analysis. Int. J. Cancer. 72:241-247.

Caux, C., B. Vanbervliet, C. Massacrier, M. Azuma, K. Okumura, L.L. Lanier and J. Banchereau. 1994. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180:1841-1847.

Cella, M., F. Sallusto and A. Lanzavecchia. 1997a. Origin, maturation and antigen-presenting function of dendritic cells. Curr. Opin. Immunol. 9:10-16.

Cella, M., A. Engering, V. Pinet, J. Pieters and A. Lanzavecchia. 1997b. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 388:782-787.

Chakkalath, H.R. and R.G. Titus. 1994. Leishmania major-parasitized macrophages augment Th2-type T cell activation. J. Immunol. 153:4378-4387.

Chang, H.L., N. Gillett, I. Figari, A.R. Lopez, M.A. Palladino and R. Derynck. 1993. Increasing transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Research. 53:4391-4398.

Chaplin, D.D. and Y. Fu. 1998. Cytokine regulation of secondary lymphoid organ development. Curr. Opin. Immunol. 10:289-297.

116

References

Chehimi, J. and G. Trinchieri. 1994. Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. 14:149-161.

Chouaib, S., C. Asselin-Paturel, F. Mami-Chouaib, A. Caignard and J.Y. Blay. 1997. The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol. Today. 18:493-497.

Colombo, M.P., A. Modesti, G. Parmiani and G. Forni. 1992. Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T­lymphocyte cross-talk. Cancer Res. 52:4853-4857.

Conti, L., J. Hiscott, M. Papacchini, A. Roulston, M.A. Wainberg, F. Belardelli and S. Gessani. 1997. Induction of relA(p65) and IKBa subunit expression during differentiation of human peripheral blood monocytes to macrophages. Cell. Growth Differ. 8:435-442.

Cook, D.N., M.A. Beck, T.M. Coffman, S.L. Kirby, J.F. Sheridan, I.B. Pragnell and 0. Smithies. 1995. Requirement of MIP-1a for an inflammatory response to viral infection. Science. 269:1583-1585.

Cooper, P.H., P. Mayer and M. ·Baggiolini. 1984. Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide: Correlation with biochemical and functional parameters. J. Immunol. 133:913-922.

Coughlin, C.M., M. Wysocka, H.L. Kurzawa, W.M. Lee, G. Trinchieri and S.L. Eck. 1995. B7-1 and interleukin-12 synergistically induce effective antitumor immunity. Cancer Res. 55:4980-4987.

Cox, G.W., G. Melillo, U. Chattopadhyay, D. Mullet, R.H. Fertel and L. Varesio. 1992. Tumor necrosis factor-a-dependent production of reactive nitrogen intermediates mediates IFN-y plus IL-2-induced murine macrophage tumoricidal activity. J. Immunol. 149:3290-3296.

Crow J.P. and H. Ischiropoulos. 1996. Detection and quantitation of nitrotyrosine residues in proteins: in vivo marker of peroxynitrite. Methods Enzymol. 269:185-194.

Cui, S., J.S. Reichner, R.B. Mateo and J.E. Albina. 1994. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or independent mechanisms. Cancer Res. 54:2462-2467.

Cui, W., D.J. Fowlis, S. Bryson, E. Duffie, H. Ireland, A. Balmain and R.J. Akhurst. 1996. TGF-beta 1 inhibits the formation of benign_ skin tumors, but

117

References

enhances progression to invasive spindle carcinomas in transgenic mice. Cell. 86:531-542.

Dacosta, N.A. and S.G. Kinare. 1991. Association of lung carcinoma and tuberculosis J. Postgrad. Med. 37:185-189.

D'Andrea, A., M. Rengaraju, N.M. Valiante, J. Chehimi, M. Kubin, M. Aste, S.H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S.F. Wolf and G. Trinchieri. 1992. Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387-1398.

D'Andrea, A., M. Aste-Amezaga, N.M. Valiante, X. Ma, M. Kubin and G. Trinchieri. 1993. Interleukin-1 0 (IL-l 0) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041-1048.

Decker, T., M.L. Lohmann Matthesm and G.E. Gifford. 1987. Cell-associated tumor necrosis factor . (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol. 138:957-962.

Decker, K. 1990. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192:245-261.

Deniz, G., M. Akdis, E. Aktas, K. Blaser and C.A. Akdis. 2002. Human NK.l and NK2 subsets determined by purification of IFN-gamma-secreting and IFN­gamma-nonsecreting NK cells. Eur. J. Immunol. 32:879-884.

Desmedt, M., P. Rottiers, H. Dooms, W. Fiers and J. Grooten. 1998. Macrophages induce cellular immunity by activating Th 1 cell responses and suppressing Th2 cell responses. J. Immunol. 160:5300-5308.

Devitt, A., O.D. Moffatt, C. Raykundalia, J.D. Capra, D.L. Simmons and C.D. Gregory. 1998. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature. 392:505-509.

Diefenbach A., A.M. Jamieson, S.D. Liu, N. Shastri and D.H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation ofNK cells and macrophages. Nat. Immunol. 1:119-126.

Diefenbach A., J.K. Hsia, M.Y. Hsiung and D.H. Raulet. 2003. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur. J. Immunol. 33:381-391.

Dieu, M.C., B. Vanbervliet, A. Vicari, J.M. Bridon, E. Oldham, S. Ait-Yahia, F. Briere, A. Zlotnik, S. Lebecque and C. Caux. 1998. Selective recruitment of

118

References

immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188:373-386.

Dieu-Nosjean, M.C., A. Vicari, S. Lebecque and C. Caux. 1999. Regulation of dendritic cell trafficking: a process which involves the participation of selective chemokines. J. Leukoc. Bioi. 66:252-262.

Dieu-Nosjean, M.C., C. Massacrier, B. Homey, B. Vanbervliet, J.J. Pin, A. Vicari, S. Lebecque, C. Dezutter-Dambuyant, D. Schmitt, A. Zlotnik and C. Caux. 2000. MIP-3a is expressed at inflamed epithelial surfaces, and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192:705-718.

Drapier, J.C. and J.B. Hibbs, Jr. 1988. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol. 140:2829-2838.

Drapier, J.C., J. Wietzerbin and J.B. Hibbs, Jr. 1988. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol. 18:1587-1592.

Eiserich, J.P., C.E. Cross, A.D. Jones, B. Halliwell and A. van der Vliet. 1996. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J. Bioi. Chern. 271:19199-19208.

Elgert, K.D. and K.M. Connolly. 1978. Macrophage regulation of the T cell allogeneic response during tumor growth. Cell. Immunol. 35:1-14.

Elgert, K.D., D.G. Alleva and D.W. Mullins. 1998. Tumor-induced immune dysfunction: the macrophage connection. J. Leukoc. Bioi. 64:275-290.

Engleman, E.G. 2003. Dendritic cell-based cancer immunotherapy. Semin Oncol. 30:23-29.

Espevik, T., I.S. Figari, M.R. Shalaby, G.A. Lackides, G.D. Lewis, H.M. Shepard and M.A. Palladino, Jr. 1987. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J. Exp. Med. 166:571-576.

Ezekowitz, R.A. and S. Gordon. 1984. Alterations of surface properties by macrophage activation: expression of receptors for Fe and mannose-terminal glycoproteins and differentiation antigens. Contemp. Top. Immunobiol. 13:33-56.

119

References

Fadok, V.A., D.L. Bratton, S. Courtney Frasch, M.L. Warner and P.M. Henson. 1998. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell. Death Diff. 5:551-562.

Fantuzzi, L., P. Eid, W. Malorni, G. Rainaldi, M.C. Gauzzi, S. Pellegrini, F. Belardelli and S. Gessani. 1997. Post-transcriptional up-regulation of the cell surface-associated a component of the human type I interferon receptor during differentiation of peripheral blood monocytes: role in the biological response to type I interferon. Eur. J. Immunol. 27:1075-1081.

Fantuzzi, L., L. Conti, M.C. Gauzzi, P. Eid, M. Del Corno, B. Varano, I. Canini, F. Belardelli and S. Gessani. 2000. Regulation of chemokine/cytokine network during in vitro differentiation and HIV -1 infection of human monocytes: possible importance in the pathogenesis of AIDS. J. Leukoc. Biol. 68:391-399.

Farias Eisner, R., M.P. Sherman, E. Aeberhard and G. Chaudhuri. 1994. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA. 91:9407-9411.

Fecci, P.E., D.A. Mitchell, G.E. Archer, M.A. Morse, H.K. Lyerly, D.D. Bigner and J.H. Sampson. 2003. The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors. J Neurooncol. 64:161-176.

Fell, A.H., P.M. Preston and J.D. Ansell. 1990. Establishment of Theileria­infected bovine cell lines in scid mice. Parasite Immunol. 12:335-339.

Flavell, R.A. 2002. The relationship of inflammation and initiation of autoimmune disease: role of TNF super family members. Curr. Top. Microbiol. Immunol. 266:1-9.

Forster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Muller, E. Wolf and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 99:23-33.

Fossum, S. 1988. Lymph-borne dendritic leukocytes do not recirculate, but enter the lymph node paracortex to become interdigitating cells. Scand. J. Immunol. 27:97-105.

Fox, F.E., R.J. Capocasale, H.C. Ford, R.J. Lamb, J.S. Moore and P.C. Nowell. 1992. Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets. Lymphokine Cytokine Res. 11:299-305.

Foxman, E.F., J.J. Campbell and E.C. Butcher. 1997. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 139: 1349-1360.

120

References

Fujiwara, H. and T. Hamaoka. 1997. The anti-tumor effects of IL-12 involve enhanced IFN-y production by anti-tumor T cells, their accumulation to tumor sites and in situ IFN-y production. Leukemia. 3:570-571.

Gao, J., D.C. Morrison, T.J. Parmely, S.W. Russell and W.J. Murphy. 1997. An interferon-y-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-y and lipopolysaccharide. J. Biol. Chern. 272:1226-1230.

Garner, R.E., A.P. Malick, A.D. Yurochko and K.D. Elgert. 1987. Shifts in macrophage (Mphi) surface phenotypes during tumor growth: association ofMac-2+ and Mac-3+ M phi with immunosuppressive activity. Cell Immunol. 108:255-268.

Gately, M.K., U. Gubler, M.J. Brunda, R.R. Nadeau, T.D. Anderson, J.M. Lipman and U. Sarmiento. 1994. Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases. Ther. Immunol. 1: 187-196.

Geiser, A.G., J.J. Letterio, A.B. Kulkarni, S. Karlsson, A.B. Roberts and M.B. Sporn. 1993. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc. Natl. Acad. Sci. U. S. A. 90:9944-9948.

Gerber, J.S. and D.M. Mosser. 2001. Reversing lipopolysaccharide toxicity by ligating the macrophage Fey receptors. J. Immunol. 166:6861-6868.

Gessani, S., U. Testa, B. Varano, P. Di Marzio, P. Borghi, L. Conti, T. Barberi, E. Tritarelli, R. Martucci, D. Seripa, C. Peschle, and F. Belardelli. 1993. Enhanced production of LPS-induced cytokines during differentiation of human monocyte to macrophages. Role ofLPS receptors. J. Immunol. 151:3758-3766.

Girardi, M., C. Berger, D. Hanlon and R.L. Edelson. 2002. Efficient tumor antigen loading of dendritic antigen-presenting cells by transimmunization. Techno!. Cancer Res. Treat. 1:65-69.

Goossens, V., J. Grooten, K. DeVos and W. Fiers. 1995. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA. 92:8115-8119.

Gordon, S. 1998. The role of the macrophage in immune regulation. Res. Immunol. 149:685-688.

121

References

Gosiewska, A., C.F. Yi, 0. Blane-Brode and J.C. Geesin. 1999. Characterization of a macrophage-based system for studying the activation of latent TGF-beta. Methods Cell Sci. 21:47-56.

Govinden, R. and K.D. Bhoola. 2003. Genealogy, expression, and cellular function oftransforming growth factor-beta. Pharmacol. Ther. 98:257-265.

Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok and S.R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [ 15N] nitrate in biological fluids. Anal. Biochem. 126:131-138.

Green, S.J., T.Y. Chen, R.M. Crawford, C.A. Nacy, D.C. Morrison and M.S. Meltzer. 1992. Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-gamma and monoclonal antibodies against the 73 kDa lipopolysaccharide receptor. J. Immunol. 149:2069-2075.

Gregory, C.D. 1998. Phagocytic clearance of apoptotic cells: food for thought. Cell Death Diff. 5:549-550.

Greiss, J.P. 1879. Ber. Deutsche Chern. Ges. 12:426-428.

Gretz, J.E., A.O. Anderson and S. Shaw. 1997. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol. Rev. 156:11-24.

Grewal, I.S. and R.A. Flavell. 1996. A central role of CD40 ligand in the regulation ofCD41 T cell responses. Immunol. Today. 17:410-414.

Grohmann, U., M.L. Belladonna, C. Vacca, R. Bianchi, F. Fallarino, C. Orabona, M.C. Fioretti and P. Puccetti. 2001. Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma. J. Immunol. 167:221-227.

Gunn, M.D., K. Tangemann, C. Tam, J.G. Cyster, S.D. Rosen and L.T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA. 95:258-263.

Gunn, M.D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L.T. Williams and H. Nakano. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451-460.

Haak-Frendscho, M., T.A. Wynn, C.J. Czuprynski and D. Paulnock. 1990. Transforming growth factor-beta 1 inhibits activation of macrophage cell line RAW 264.7 for cell killing. Clin. Exp. Immunol. 82:404-410.

122

References

Harlow, E. and D. Lane. 1988. In Antibodies, a laboratory manual. Cold Spring Harbor Laboratory, USA.

Hart, D.N.J. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 90:3245-3286.

Hausmann, E.H., S.Y. Hao, J.L. Pace and M.J. Parmely. 1994. Transforming growth factor beta 1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages. Infect. Immun. 62:3625-3632.

Heigold, S., C. Sers, W. Bechtel, B. Ivanovas, R. Schafer, and G. Bauer. 2002. Nitric oxide mediates apoptosis induction selectively in transformed fibroblasts compared to non transformed fibroblasts. Carcinogenesis. 23:929-941.

Heike, Y., M. Takahashi, T. Ohira, I. Naruse, S. Hama, Y. Ohe, T. Kasai, H. Fukumoto, K.J. Olsen, E.E. Podack and N. Sajjo. 1997. Genetic immunotherapy by intrapleural, intraperitoneal and subcutaneous injection ofiL-2 gene-modified Lewis lung carcinoma cells. Int. J. Cancer. 73:844-849.

Hendriks, H.R. and I.L. Eestermans. 1983. Disappearance and reappearance of high endothelial venules and immigrating lymphocytes in lymph nodes deprived of afferent lymphatic vessels: a possible regulatory role of macrophages in lymphocyte migration. Eur. J. Immunol. 13:663-669.

Hendrzak, J.A. and M.J. Brunda. 1996. Antitumor and antimetastatic activity ofinterleukin-12. Curr. Top. Microbiol. Immunol. 213:65-83.

Henry, Y., M. Lepoivre, J.C. Drapier, C. Ducrocq, J.L. Boucher and A. Guissani. 1993. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7:1124-1134.

Herdener, M., S. Heigold, M. Saran and G. Bauer. 2000. Target cell-derived superoxide anions cause efficiency and selectivity of intercellular induction of apoptosis. Free Radic. Bioi. Med. 29:1260-1271.

Hibbs, J.B. Jr., R.R. Taintor, A. Chapman Jr. and J.B. Weinberg. 1977. Macrophage tumor killing: influence of the local environment. Science. 197:279-283.

Hibbs, J.B. Jr., R.R. Taintor, Z. Vavrin and E.M. Rachlin. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:87-94.

Hill, L.L., B. Perussia, P.A. McCue and R. Korngold. 1994. Effect of human natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency. Cancer Res. 54:763-770.

123

References

Hill, A.D., H.A. Naama, S.E. Calvano and J.M. Daly. 1995. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications. J. Leukoc. Biol. 58:634-642.

Hirao, M., N. Onai, K. Hiroishi, S.C. Watkins, K. Matsushima, P.D. Robbins, M.T. Lotze and H. Tahara. 2000. CC Chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from tumor site to draining lymph nodes. Cancer Res. 60:2209-2217.

Hiscox, S. and W.G. Jiang. 1997. Interleukin-12, an emerging anti-tumor cytokine. In Vivo. 11:125-132.

Hjelmstrom, P. 2001. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leuk. Biol. 69:331-339.

Ho, A.S. and K.W. Moore. 1994. Interleukin-10 and its receptor. Ther. Immunol. 1:173-185.

Hori, K., M.J. Ehrkl, K. Mace and E. Mihich. 1987. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon. Cancer Res. 47:5868-5874.

Hori, K., E. Mihich and M.J. Ehrke. 1989. Role of tumor necrosis factor and interleukin-1 in y-interferon-promoted activation of mouse tumoricidal macrophages. Cancer Res. 49:2606-2614.

Hromas, R., P.W. Gray, D. Chantry, R. Godiska, M. Krathwohl, K. Fife, G.I. Bell, J. Takeda, S. Aronica, M. Gordon, S. Cooper, H.E. Broxmeyer and M.J. Klemsz. 1997. Cloning and characterization of exodus, a novel beta-chemokine. Blood. 89:3315-3322.

Huang, M., J. Wang, P. Lee, S. Sharma, J.T. Mao, H. Meissner, K. Uyemura, R. Modlin, J. Wollman and S.M. Dubinett. 1995. Human non-small cell lung cacer cells express a type 2 cytokine pattern. Cancer Res. 55:3847-3853.

Huang X. and C. Lee. 2003. From TGF-beta to cancer therapy. Curr. Drug Targets. 4:243-250.

Huynh, M.L., V.A. Fadok and P.M. Henson. 2002. Phosphatidylserine­dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109:41-50.

124

References

Igarashi, T., D. Rodrigues and C.-C. Ting. 1979. Studies of the mechanisms for the induction of in vivo tumor immunity. IV. Enhancement of the in vitro generation of secondary cell-mediated cytotoxic response by normal peritoneal macrophages and their culture supernatants. J. Immunol. 122:1519-1527.

Inaba, K., G. Schuler, M.D. Witmer, J. Valinksy, B. Atassi, and R.M. Steinman. 1986. Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J. Exp. Med. 164:605-613.

Inaba, K., M. Witmer-Pack, M. Inaba, K.S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P.S. Linsley, S. Ikehara, S. Muramatsu, R.J. Hodes and R.M. Steinman. 1994. The tissue distribution of the B7.2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849-1860.

Irani, K., Y. Xia, J.L. Zweier, S.J. Sollott, C.J. Der, E.R. Fearon, M. Sundaresan, T. Finkel and P.J. Goldschmidt-Clermont. 1997. Mitogenic signaling by oxidants in Ras-transformed fibroblasts. Science. 275:1649-1652.

Ischiropoulos, H., L. Zhu and J.S. Beckman. 1992. Peroxynitrite formation from macrophage derived nitric oxide. Arch. Biochem. Biophys. 298:44~51.

Iwasaki, A. and B.L. Kelsall. 2000. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3a, MIP-3p, and secondary lymphoid organ chemokine. J. Exp. Med. 191:1381-1393.

Jeong, J.Y. and D.M. Jue. 1997. Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages. J. Immunol. 158:4901-4907.

Johnson, R.B. 1988. Current concepts: immunology. Monocytes and macrophages. N. Engl. J. Med. 318:747-752.

Jordens, R., A. Thompson, R. Amons and F. Koning. 1999. Human dendritic cells shed a functional, soluble form of the mannose receptor. Int. Immunol. 11:1775-1780.

Kaplan, G. and G. Gaudernack. 1982. In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J. Exp. Med. 156:1101-1114.

Kaplan, G., G. Walsh, L.S. Guido, P. Meyn, R.A. Burkhardt, R.M. Abalos, J. Barker, P.A. Frindt, T.T. Fajardo, R. Celona and Z.A. Cohn. 1992. Novel

125

Kejerences

responses of human factor: Langerhans cell recruitment, keratinocyte growth and enhanced wound healing. J. Exp. Med.175:1717-1728.

Kausalya S., S.P. Hegde, J.J. Bright and A. Khar. 1994. Mechanism of antibody dependent natural killer cell-mediated AK-5 tumor cell death. Exp. Cell Res. 212:285-290.

Kehrl, J.H., L.M. Wakefield, A.B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M.B. Sporn and A.S. Fauci. 1986. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037-1050.

Keller, R., M. Geiges and R. Keist. 1990. L-arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages. Cancer Res. 50:1421-1425.

Khar, A. 1986. Development and characterization of a rat histiocyte-macrophage tumor line. J. Natl. Cancer Inst. 76:871-878.

Khar, A. 1993. Characterization of spontaneous immunological rejection in a histiocytoma. I. Role of NK cells and antitumor antibodies. Int. J. Oncol. 3:393-398.

Khar, A. and M. Ali. 1990. Adaptation of rat histiocytoma cells AK-5, to growth in culture. In Vitro Cell. Dev. Biol. 26: 1024-1025.

Kleeff, J., T. Kusama, D.L. Rossi, T. Ishiwata, H. Maruyama, H. Friess, M.W. Buchler, A. Zlotnik and M. Korc. 1999. Detection and localization of MIP-3alpha!LARC/Exodus, a macrophage proinflarnrnatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int. J. Cancer. 81:650-657.

Konishi, Y., S. Takahashi, M. Sunagawa, N. Miyagi and H. Kondo. 1978. ·Heterotransplantation into nude mice of pancreatic carcinoma induced by N­bis(2-hydroxypropyl)nitrosamine in hamsters. Cancer Lett. 5:333-337.

Kripke, M.L., C.G. Munn, A. Jeevan, J.-M. Tang and C. Bucana. 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145:2833-2838.

Krist, L.F., I.L. Eestermans, J.J. Steenbergen, E.C. Hoefsmit, M.A. Cuesta, S. Meyer and R.H. Beelen. 1995. Cellular composition of milky spots in the human greater omentum: an immunochemical and ultrastructural study. Anat. Rec. 241:163-174.

Kroemer, G., I.M. de Alboran, J.A. Gonzalo and C. Martinez-A. 1993. Immunoregulation by cytokines. Crit. Rev. Immunol. 13:163-191.

126

References

Kroncke, K.D., K. Fehsel, T. Schmidt, F.T. Zenke, I. Dasting, J.R. Wesener, H. Bettermann, K.D. Breunig and V. Kolb-Bachofen. 1994. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem. Biophys. Res. Commun. 200:1105-1110.

Kroncke, K.D., K. Fehsel and V. Kolb-Bachofen. 1995. Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Bioi. Chern. Hoppe. Seyler. 376:327-343.

Kruitwagen, R.F., L.G. Poels, W.N. Willemsen, H.J. Croes, D.F. Smeets, J.L. Beck, A.G. Hanselaar, F.C. Ramaekers, R. Rolland and P.H. Jap. 1989. ETN-1: a new human endometrial carcinoma cell line producing ascites and distant metastases in nude mice. Int. J. Cancer. 43:1098-1103.

Kuby, J. 1997./n Immunology, 3rd edition. W.H. Freeman, ed. New York, USA.

Kulkarni, A.B., C.C. Hun, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward and S. Karlsson. 1993. Transforming growth factor-J31 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:770-774.

Kupiec-Weglinski, J.W., J.M. Austyn and P.J. Morris. 1988. Migration patterns of dendritic cells in the mouse. Traffic from blood, and T cell-dependent and independent entry to lymphoid tissues. J. Exp. Med. 167:632-645.

Kuroki, H., T. Morisaki, K. Matsumoto, H. Onishi, E. Baba, M. Tanaka and M. Katano. 2003. Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use. Cancer Immunol Immunother. [Epub ahead of print].

Larsen, C.P., R.M. Steinman, M.D. Witmer-Pack, D.F. Hankins, P.J. Morris and J.M. Austyn. 1990. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172:1483-1494.

Laskin, D.L. and J.D. Laskin. 1997. Phagocytes. In Comprehensive Toxicology, vol. 5, Toxicology of the Immune System, Lawrence, D. A. eds. Pergamon New York, USA.

Lee, J., B. Fenton, C.J. Koch, J.G. Frelinger and E.M. Lord. 1998. Interleukin-2 expression by tumor cells alters both the immune response and the tumor microenvironment. Cancer Res. 58: 14 78-1485.

127

References

Lin, H., R.Q. Wei and S.F. Bolling. 1995. Tumor necrosis factor-alpha and interferon-gamma modulation of nitric oxide and allograft survival. J. Surg. Res. 59:103-110.

Loachim, H.L. 1990. The opportunistic tumors of immune deficiency. Adv. Cancer Res. 54:301-317.

Luscher, U., L. Filgueira, A. Juretic, M. Zuber, N.J. Luscher, M. Heberer and G.C. Spagnoli. 1994. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes. Int. J. Cancer. 57:612-619.

Luther, S.A., A. Bidgol, D.C. Hargreaves, A. Schmidt, Y. Xu, J. Paniyadi, M. Matloubian and J.G. Cyster. 2002. Differing activities of homeostatic chemokines CCL19, CCL21 and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169:424-433.

Macatonia, S.E., S.C. Knight, A.J. Edwards, S. Griffiths and P. Fryer. 1987. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorscein isothiocyanate. J. Exp. Med. 166:1654-1667.

Maeda, S., D.D. Dean, R. Gomez, Z. Schwartz and B.D. Boyan. 2002. The first stage of transforming growth factor-beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Calcif. Tissue Int. 70:54-65.

Majewski, S., M. Marczak, A. Szmurlo, S. Jablonska and W. Bollag. 1996. Interleukin-12 inhibits angiogenesis induced by human tumor cell lines in vivo. J. Invest. Dermatol. 106: 1114-1118.

Mandelboim, 0., S. Kent, D.M. Davis, S.B. Wilson, T. Okazaki, R. Jackson, D. Hatler and J.L. Strominger. 1998. Natural killer activating receptors trigger interferon-gamma secretion from T cells and natural killer cells. Proc. Natl. Acad. Sci. USA. 95:3798-3803.

Mantovani, A. 1999. The chemokine system: redundancy for robust outputs. Immunol. Today. 20:254-257.

Marchesi, V.T. and J.L. Gowans. 1964. The migration of lymphocytes through the endothelium of venules in lymph nodes: an electron microscope study. Proc. R. Soc. Lond B. Bioi. Sci. 159:283-290.

Mariathasan, S., M. Matsumoto, F. Baranyay, M.H. Nahm, 0. Kanagawa and D.D. Chaplin. 1995. Absence of lymph nodes in lymphotoxin-alpha(LT alpha)-deficient mice is due to abnormal organ development, not defective lymphocyte migration. J. Inflamm. 45:72-78.

128

References

Marr, R.A., C.L. Addison, D. Snider, W.J. Muller, J. Gauldie and F.L. Graham. 1997. Tumor immunotherapy using an adenoviral vector expressing a membrane-bound mutant ofmurine TNF-alpha. Gene Ther. 4:1181-1188.

Matsumoto, M., Y.X. Fy, H. Molina and D.D. Chaplin. 1997. Lymphotoxin­alpha-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. Immunol. Rev. 156:137-144.

Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991-1045.

Maurer, D., E. Fiebiger, B. Reininger, C. Ebner, P. Petzelbauer, G.P. Shi, H.A. Chapman and G. Stingl. 1998. Fe epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation. J. Immunol. 161:2731-2739.

Melero, I., G. Mazzolini, I. Narvaiza, C. Qian, L. Chen and J. Prieto. 2001. IL-12 gene therapy for cancer: in synergy with other immunotherapies. Immunol. Today. 22:113-115.

Melichar, B. and R.S. Freedman. 2002. Immunology of the peritoneal cavity: Relevance for host-tumor relation. Int. J. Gynecol. Cancer. 12:3-17.

Merly, F., C. Huard, I. Asselin, P.D. Robbins and J.P. Tremblay. 1998. Anti­inflammatory effect of transforming growth factor-beta1 in myoblast transplantation. Transplantation. 65:793-799.

Miyazono, K., U. Hellman, C. Wenstedt and C.-H. Beldin 1988. Latent High Molecular Weight Complex of Transforming Growth Factor Beta-1: Purification from human platelets and structural characterization. J. Biol. Chern. 263:6407-6415.

Monastra, G., A. Cabrelle, A. Zambon, A. Rosato, B. Macino, D. Collavo and P. Zanovello. 1996. Membrane form of TNF-alpha induces both cell lysis and apoptosis in susceptible target cells. Cell. Immunol. 171:102-110.

Moncada, S., R.M. Palmer and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacal. Reviews. 43: 109-142.

Morrison, A.C. and P.H. Correll. 2002. Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages J. Immunol. 168:853-860.

129

Mosmann, T.R. and R.L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.

Mosser, D.M. and E. Handman. 1992. Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes. J. Leukoc. Biol. 52:369-376.

Mueller, D., M.K. Jenkins and R.H. Schwartz. 1989. Clonal expansion versus functional inactivation: a costimulatory signaling pathway determines the outcome ofT cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445-480.

Mule, J.J., S.L. Schwarz, A.B. Roberts, M.B. Sporn and S.A. Rosenberg. 1988. Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol. Immunother. 26:95-100.

Muller, W.A. 2001. New mechanisms and pathways for monocyte recruitment. J. Exp. Med. 194:F47-F51.

Muller, G., U.E. Hopken and M. Lipp. 2003. The impact ofCCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol. Rev. 195:117-135.

Mullins, D.W., R.S. Martins, C.J. Burger and K.D. Elgert. 2001. Tumor cell­derived TGF-f3 and IL-10 dysregulate paclitaxel-induced macrophage activation. J. Leukoc. Biol. 69:129-137.

Muon, D.H. and N.K.V. Cheung. 1990. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J. Exp.Med. 172:231-23 7.

Muralikrishna, T., Z. Begum, Ch.V.B. Swamy and A. Khar. 1998. Molecular cloning and characterization of a tumor rejection antigen from a rat histiocytoma, AK-5. DNA Cell Biol. 17: 603-612.

Muzio, M., M. Sironi, N. Polentarutti, A. Mantovani and F. Colotta. 1994. Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells. Eur. J. Immunol. 24:3194-3198.

Nakamura, E., H. Kubota, M. Sato, T. Sugie, 0. Yoshida and N. Minato. 1997. Involvement ofNK1+CD4-CD8-alphabeta T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice. J. Immunol. 158:5338-5348.

130

Rejerences

Nagira, M., T. Imai, K. Hieshima, J. Kusuda, M. Ridanpaa, S. Takagi, M. Nishimura, M. Kakizaki, H. Nomiyama and 0. Yoshie. 1997. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J. Biol. Chern. 272:19518-19524.

Nagy, J.A., E.M. Masse, K.T. Herzberg, M.S. Meyers, K.T. Yeo, T.K. Yeo, T.M. Sioussat and H.F. Dvorak. 1995. Pathogenesis of ascites tumor growth: Vascular permeability factor, vascular hyperpermeability and ascites fluid accumulation. Cancer Res. 55:360-368.

Nastala, C.L., H.D. Edington, T.G. McKinney, H. Tahara, M.A. Nalesnik, M.J. Brunda, M.K. Gately, S.F. Wolf, R.D. Schreiber, W.J. Storkus and M.T. Lotze. 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-y production. J. Immunol. 153:1697-1706.

Nathan, C.F. 1987. Secretory products ofmacrophages. J. Clin. Invest. 79:319-326.

Nathan, C.F. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3054.

Nathan, C.F. 1999. Mechanisms and modulation of macrophage activation. Behring Inst. Res. Commun. 88:200-207.

Nathan, C.F. and J.B. Hibbs, Jr. 1991. Role of nitric oxide synthesis m macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.

Nathan, C. and Q. Xie. 1994. Regulation ofbiosynthesis of nitric oxide. J. Biol. Chern., 269:13725-13728.

Newman, S.L., J.E. Henson and P.M. Henson. 1982. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J. Exp. Med. 156:430--442.

Ngo, V.N., H.L. Tang and J.G. Cyster. 1998. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J. Exp. Med. 188:181-191.

Ngo, V.N., H. Korner, M.L. Gunn, K.N. Schmidt, D.S. Rimington, M.D. Cooper, J.L. Browning, J.D. Sedgwick and J.G. Cyster. 1999. Lymphotoxin a/!3 and tumor necrosis factor are required for stromal cell expression of homing chemokines in T and B cell areas ofthe spleen. J. Exp. Med. 189:403-412.

131

References

North, R.J. 1978. The concept of the activated macrophage. J. Immunol. 121:806-809.

O'Garra, A. and K. Murphy. 1994. Role of cytokines m determining T­lymphocyte function. Curr. Opin. Immunol. 6:458-466.

Ogura, T., M. Tatemichi and H. Esumi. 1997. TNF-alpha mediates inducible nitric oxide synthase expression in human neuroblastoma cell line by cisplatin. Biochem. Biophys. Res. Commun. 233:788-791.

Onaitis, M.W., M.F. Kalady, S. Emani, Z. Abdel-Wahab7 D.S. Tyler and S.K. Pruitt. 2003. CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy. Surgery. 134:300-305.

Osugi, Y., S. Vuckovic and D.N. Hart. 2002. Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood. 100:2858-2866.

Otova, B., V. Kren, A. Bukovsky and J. Pospichalova. 1987. The cross­reaction patterns ofthe MRC OX-3, OX-6, and OX-17 monoclonal antibodies on rat inbred and congenic strains. Folia Biol (Praha). 33:363-366.

Palucka K.A., N. Taquet, S. Sanchez-Chapuis and J.C. Gluckman. 1998. Dendritic cells as the terminal stage of monocyte differentiation. J. Immunol. 160: 4587-4595.

Papac, R.J. 1996. Spontaneous regression of cancer. Cancer Treat. Rev. 22:395-423.

Papac, R.J. 1998. Spontaneous regression of cancer: possible mechanisms. In Vivo. 12:571-578.

Parham, P. 1997. The anatomy of antigen-specific immune responses. Immunol. Rev. 156:5-209.

Penn, I. 1990. Cancers complicating organ transplantation. N. Engl. J. Med. 323:1767-1769.

Perez, V.L., J.A. Lederer, A.H. Lichtman and A.K. Abbas. 1995. Stability of Th1 and Th2 populations. Int. Immunol. 7:869-875.

Pestka, S., S.V. Kotenko, G. Muthukumaran, L.S. Izotova, J.R. Cook and G. Garotta. 1997. The interferon-gamma (IFN-gamma) receptor: a paradigm for the mu1tichain cytokine receptor. Cytokine Growth Factor Rev. 8:189-206.

132

Petit-Koskas, E., E. Genot, D. Lawrence and J.P. Kolb. 1988. Inhibition of the proliferative response of human B-lymphocytes to B cell growth factor by transforming growth factor-beta. J. Immunol. 18:111-116.

Platt, N., H. Suzuki, J. Kurihara, I. Kodama and S. Gordon. 1996. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl. Acad. Sci. USA. 93:12456-12460.

Pospisilova, D., J. Borovickova, A. Polouckova, R. Spisek, A. Sediva, 0. Hrusak, J. Stary and J. Bartunkova. 2002. Generation of functional dendritic cells for potential use in the treatment of acute lymphoblastic leukemia. Cancer Immunol. Immunother. 51:72-78.

Pure, E., K. Inaba, M.T. Crowley, L. Tardelli, M.D. Witmer-Pack, G. Roberti, G. Fathman and R.M. Steinman. 1990. Antigen processing by epidermal Langerhans cells correlates with the level ofbiosynthesis ofMHC class II molecules and expression of invariant chain. J. Exp. Med. 172:1459-1469.

Qin, S., J.B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A.E. Koch, B. Moser and C.R. Mackay. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets ofT cells associated with certain inflammatory reactions. J. Clin. Investig. 101:746-754.

Rabkin, C.S., M.W. Hilgartner, K.W. Hedberg, L.M. Aledort, A. Hatzakis, S. Eichinger, M.E. Eyster, G.C. White 2"d, C.M. Kessler and M.M. Lederman. 1992. Incidence of lymphomas and other cancers in HIV-infected and HIV­uninfected patients with hemophilia. JAMA. 267:1090-1094.

Reddy, J., P. Chastagner, L. Fiette, X. Lieu and J. Theze. 2001. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis of IL-2 knockout model and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation. Int. Immunol. 13:135-147.

Reed, S.G. 1999. TGF-beta in infections and infectious diseases. Microbes Infect. 1:1313-1325.

Regnault, A., D. Lankar, V. Lacabanne, A. Rodriguez, C. Thery, M. Rescigno, T. Saito, S. Verbeek, C. Bonnerot, P. Ricciardi-Castagnoli and S. Amigorena. 1999. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class !-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:371-380.

Ren, Y., R.L. Silverstein, J. Allen and J. Savill. 1995. CD36 gene transfer confers capacity for phagocytosis of cells to undergoing apoptosis. J .. Exp. Med. 181:1857-1862.

133

References

Ren, Y. and J. Savill. 1998. The importance of being eaten. Cell Death Diff. 5:563-568.

Revel, M. and J. Chebath. 1986. Interferon-activated genes. Trends Biochem. Sci. 11:166-170.

Rich, E.A., I.S. Chen, J.A. Zack, M.L. Leonard and W.A. O'Brien. 1992. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J. Clin. Invest. 89:176-183.

Richter, C., V. Gogvadze, R. Schlapbach, M. Schweizer and J. Schlegel. 1994. Nitric oxide kills hepatocytes by mobilizing mitochondrial calcium. Biochem. Biophys. Res. Commun. 205:1143-1150.

Robey, E. and J.P. Allison. 1995. T cell activation: integration of signals from the antigen receptor and co-stimulatory molecules. Immunol. Today. 16:306-310.

Robinson, A.P., T.M. White and D.W. Mason. 1986. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology. 57:239-247.

Rogoff, T.M. and P.E. Lipsky. 1980. Antigen presentation by isolated guinea pig Kupffer cells J. Immunol. 124:1740-1744.

Roitt, I.M. and P.J. Delves. 1992. In Encyclopedia of Immunology, Harcourt Brace Jovanovich Publishers, Academic Press, London, UK.

Rollin, B.J. 1997. Chemokines. Blood. 90: 909-928.

Romani, N., S. Koide, M. Crowley, M. Witmer-Pack, A.M. Livingstone, C.G. Fathman, K. Inaba and R.M. Steinman. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact Protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169:1169-1178.

Rook, A.H., J.H. Kehrl, L.M. Wakefield, A.B. Roberts, M.B. Sporn, D.B. Burlington, H.C. Lane and A.S. Fauci. 1986. Effects of transforming growth factor-beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136:3916-3920.

Rosenthal, F.M., K. Cronin, R. Bannerji, D.W. Golde and B. Gansbacher. 1994. Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-y cDNAs. Blood. 83:1289-1294.

134

References

Rossi, D.L., A.P. Vicari, K. Franz-Bacon, T.K. McClanahan and A. Zlotnik. 1997. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3a and MIP-3f3. J. Immunol. 158:1033-1036.

Rossiter, H., R. Alon and T.S. Kupper. 1997. Selectins, T-cell rolling and inflammation. Mol. Med. Today. 3:214-222.

Rovere, P., C. Vallinoto, A. Bondanza, M. Crosti, M. Rescigno, P. Ricciardi­Castagnoli, C. Rugarli and A.A. Manfredi. 1998. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. 159:5391-5399.

Rovere, P., M.G. Sabbadini, C. Vallinoto, U. Fascio, V.S. Zimmermann, A. Bondanza, P. Ricciardi-Castagnoli and A.A. Manfredi. 1999. Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells. J. Leukoc. Bioi. 66:345-349.

Rubin, S.C., M.G. Federici, K.O. Lloyd, J.L. Lewis Jr and W.J. Hoskins. 1992. Characterization of a human endometrial carcinoma cell line producing intraperitoneal tumor growth in immunodeficient mice. Gynecol. Oncol. 45:273-278.

Salloum, E., D.L. Cooper, G. Howe, J. Lacy, G. Tallini, J. Crouch, M. Schultz and J. Murren. 1996. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid disorders and other rheumatic diseases. J. Clin. Oncol. 14:1943-1949.

Sallusto, F. and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor-alpha. J. Exp. Med. 179:1109-1118.

Sallusto, F., M. Cella, C. Danieli and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400.

Sallusto, F., P. Schaerli, P. Loetscher, C. Schaniel, D. Lenig, C.R. Mackay, S. Qin and A. Lanzavecchia. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28:2760-2769.

Sallusto, F. and A. Lanzavecchia. 1999. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189:611-614.

135

References

Sallusto, F., B. Palermo, D. Lenig, M. Miettinen, S. Matikainen, I. Julkunen, R. Forster, R. Burgstahler, M. Lipp and A. Lanzavecchia. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function Eur. J. Immunol. 29:1617-1625.

Sambrook J., E.F. Fritsch and T. Maniatis. 1989. Molecular Cloning: a laboratory manual. II edition. Cold Spring Harbor Laboratory Press.

Sanchez-Bueno, A., V. Verkhusha, Y. Tanaka, 0. Takikawa and R. Yoshida. 1996. Interferon-y-dependent expression of inducible nitric oxide synthase, interleukin-12, and interferon-y-inducing factor in macrophages elicited by allografted tumor cells. Biochem. Biophys. Res. Commun. 224:555-563.

Satoh, M., S. Seki, W. Hashimoto, K. Ogasawara, T. Kobayashi, K. Kumagai, S. Matsuno and K. Takeda. 1996. Cytotoxic y8 or ap T cells with natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination ofiL-12 and IL-2. J. Immunol. 157:3886-3892.

Savill, J. 1998. Phagocytic docking without shocking. Nature. 392:442-443.

Schroder, M., C. Meisel, K. Buhl, N. Profanter, N. Sievert, H.D. Volk and G. Grutz. 2003. Different Modes of IL-10 and TGF-beta to Inhibit Cytokine­Dependent IFN-gamma Production: Consequences for Reversal of Lipopolysaccharide Desensitization. J. Immunol. 170:5260-5267.

Schuler, G. and R.M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:526-546.

Seljelid, R. and L.T.R. Busund. 1994. The biology of macrophages. 2. Inflammation and tumors. Eur. J. Haematol. 52:1-12.

Seo, N. andY. Tokura. 1999. Downregulation of innate and acquired antitumor immunity by bystander gammadelta and alphabeta T lymphocytes with Th2 or Th1 cytokine profiles. J. Interferon Cytokine Res. 19:555-561.

Shrestha, A., K. Horino, H. Nishiura and T. Yamamoto. 1999. Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S 19 ribosomal protein dimer irt this connection. Lab. Invest. 79:1629-1642.

Shrikant, P., S.J. Lee, I. Kalvakolanu, R.M. Ransohoff and E.N. Benveniste. 1996. Stimulus-specific inhibition of intracellular adhesion molecule-1 gene expression by TGF-beta. J. Immunol. 157:892-900.

136

References

Shrivastava, A., A. Sodhi and R. Kumar. 1995. Activation of munne macrophages by tumor cells. Int. J. Immunopathol. Pharmacal. 8:45-56.

Shu, U., M. Kiniwa, C.Y. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1125-1128.

Skeen, M.J., M.A. Miller, T.M. Shinnick and H.K. Ziegler. 1996. Regulation of murine macrophage IL-12 production: activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J. Immunol. 156:1196-1206.

Smyth, M.J., M. Taniguchi and S.E.A. Street. 2000. The anti-tumor activity of IL-12: Mechanisms of innate immunity that are model and dose-dependent. J. Immunol. 165:2665-2670.

Solbach, W., H. Moll and M. Rollinghoff. 1991. Lymphocytes play the music but the macrophage calls the tune. Immunol. Today. 12:4-6.

Song, E., N. Ouyang, M. Horbelt, B. Antus, M. Wang and M.S. Exton. 2000. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell. Immunol. 204:19-28.

Sotomayor, E.M., Y.X. Fu, M. Lopez-Cepero, L. Herbert, J.J. Jimenez, C. Albarracin and D.M. Lopez. 1991. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down­regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte­macrophage colony-stimulating factor. J. Immunol. 147:2816-2823.

Sozzani, S., P. Allavena, G. D'Amico, W. Luini, G. Bianchi, M. Kataura, T. Imai, 0. Yoshie, R. Bonecchi and A. Mantovani. 1998. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161:1083-1086.

Sozzani S., P. Allavena, A. Vecchi and A. Mantovani. 1999. The role of chemokines in the regulation of dendritic cell trafficking. J. Leukoc. Biol. 66: 1-9.

Spiekermann, K., J. Roesler, A. Emmendoerffer, J. Elsner and K. Welte. 1997. Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications. Leukemia. 11:466-478.

Stafforini, D.M., M.R. Elsted, T.M. Mcintyre, G.A. Zimmerman and S.M. Prescott. 1990. Human macrophages secrete platelet-activating factor acetylhydrolase. J. Biol. Chern. 265:9682-9687.

137

References

Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.

Steinman R.M., M. Pack and K. lnaba. 1997. Dendritic cells in the T -cell areas oflymphoid organs. Immunol. Rev. 156:25-37.

Stein-Streilein, J., K.H. Sonoda, D. Faunce and J. Zhang-Hoover. 2000. Regulation of adaptive immune responses by innate cells expressing NK markers and antigen-transporting macrophages. J. Leukoc. Bioi. 67:488-494.

Stern, M., J. Savill and C. Haslett. 1996. Human monocyte derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by avb3/CD36/Thrombospondin recognition mechanism and lack of phlogistic response. Am. J. Pathol. 149:911-921.

Stift, A., J. Friedl, P. Dubsky, T. Bachleitner-Hofmann, G. Schueller, T. Zontsich, T. Benkoe, K. Radelbauer, C. Brostjan, R. Jakesz and M. Gnant. 2003. Dendritic cell-based vaccination in solid cancer. J. Clin. Oncol. 21:135-142.

Stout, R.D. and J. Suttles. 1996. The many roles of CD40 in cell-mediated inflammatory responses. Immunol. Today. 17:487-492.

Strassmann, G., M.D. Cole and W. Newman. 1988. Regulation of colony stimulating factor !-dependent macrophage precursor proliferation by type beta transforming growth factor. J. Immunol. 140:2645-2651.

Streilein, J.W. and S.F. Grammer. 1989. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. J. Immunol. 143:3925-3933.

Stuehr D.J. and C.F. Nathan. 1989. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543-1555.

Suffys, P., R. Beyaert, F. Van Roy and W. Fiers. 1988. Involvement of a serine protease in tumour-necrosis-factor-mediated cytotoxicity. Eur. J. Biochem. 178:257-265.

Sub, Y.-A., R.S. Arnold, B. Lassegue, J. Shi, X. Xu, D. Sorescu, A.B. Chung, K.K. Griendling and J.D. Lambeth. 1999. Cell transformation by the superoxide-generating oxidase Moxl. Nature. 401:79-82.

Sulitzeanu, D. 1993. Immunosuppressive factors in human cancer. Adv. Cancer Res. 60:247-267.

138

References

Sutterwala, F.S., G.J. Noel, R. Clynes and D.M. Mosser. 1997. Selective suppression ofinterleukin-12 induction following macrophage receptor ligation. J. Exp. Med. 185:1977-1985.

Sutterwala, F.S., G.J. Noel, P.S. Salgame and D.M. Mosser. 1998. Reversal of proinflammatory responses by ligating the macrophage FcyRI. J. Exp. Med. 188:217-222.

Sveinbjornsson, B., R. Olsen, O.M. Seternes, and R. Seljelid. 1996. Macrophage cytotoxicity against murine Meth A sarcoma involves nitric-oxide­mediated apoptosis. Biochem. Biophys. Res. Commun. 223:643-649.

Sveinbjornsson, B., C. Rushfeldt, R. Olsen, B. Smedsrod and R. Seljelid. 1997. Cytotoxic effect of cytokines on murine colon carcinoma cells involves TNF-mediated apoptosis. Biochem. Biophys. Res. Commun. 233:270-275.

Szuro-Sudol, A. and C.F. Nathan. 1982. Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells. J. Exp. Med. 156:945-961.

Tahara, H., H.J. Zeh III, W.J. Storkus, I. Pappo, S.C. Watkins, U. Gubler, S.F. Wolf, P.D. Robbins and M.T. Lotze. 1994. Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 54: 182-189.

Takai, N., M. Kataoka, Y. Higuchi, K. Matsuura and S. Yamamoto. 1997. Primary structure of rat CD 14 and characteristics of rat CD 14 cytokine, and NO synthase mRNA expression in mononuclear phagocyte system cells in response to LPS. J. Leukoc. Biol. 61:736-744.

Takao, S., E.H. Smith, D.J. Wang, C.K. Chan, G.B. Bulkley and A.S. Klein. 1996. Role of reactive oxygen metabolites in murine peritoneal macrophage phagocytosis and phagocytic killing. Am. J. Physiol. 40:C1278-1290.

Takemura, R. and Z. Werb. 1984. Secretory products ofmacrophages and their physiological functions. Am. J. Physiol. 246:Cl-C9.

Tellado, J.M., F. Broche and D. Vega. 2000. Host defense mechanisms of the peritoneal cavity. In Intrabdominal Infections. J.M. Tellado and N.V. Christou~ editors. Madrid, Harcourt. 1-11.

Testa, U., M. Petrini, M.T. Quaranta, E. Pelosi-Testa, G. Mastroberardino, A. Camagna, G. Boccoli, M. Sargiacomo, G. Isacchi, A. Cozzi, P. Arosio and C. Peschle. 1989. Iron up-modulates the expression of transferrin receptors during monocyte-macrophage maturation. J. Biol. Chern. 264:13181-13187.

139

References

Testa, U., L. Conti, N.M. Sposi, B. Varano, E. Tritarelli, E. Malorni, P. Samoggia, G. Rainaldi, C. Peschle, F. Belardelli and S. Gessani. 1995. IFN-P selectively down-regulates transferrin receptor expression in human peripheral blood macrophages by a post-translational mechanism. J. Immunol. 155:427-435.

Ting, C.C., S.C. Tsai and M.J. Rogers. 1977. Host control of tumor growth. Science. 197:571-573.

Ting, C.C. and D.J. Rodrigues. 1979. Reversal by peritoneal adherent cells of tumor cell suppression ofT cell-mediated immunity. J. Immunol. 123:801-807.

Ting, C.C., D. Rodrigues and T.J. Igarashi. 1979. Studies of the mechanisms for the induction of in vivo tumor immunity. III. Recruitment of host helper cells by donor T cells in adoptive transfer of cell-mediated immunity. J. Immunol. 122:1510-1518.

Ting, C.C. and D.J. Rodrigues. 1982. Tumor cell-triggered macrophage­mediated suppression of the T -cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression. J. Natl. Cancer Inst. 69:867-887.

Ting C.C. and M.E. Hargrove. 1982. Tumor cell-triggered macrophage­mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. II. Mechanisms for induction of suppression. J Natl Cancer Inst. 69:873-878.

Ting, C.C. and S.R. Zhang. 1983. Studies of the mechanisms for the induction of in vivo tumor immunity. VII. Development of specific antitumor immunity in progressors and regressors. Int. J. Cancer. 32:385-391.

Tomioka, H., T. Shimizu, W.W. Maw and K. Ogasawara. 2000. Roles of tumour necrosis factor-alpha (TNF-alpha), transforming growth factor-beta (TGF­beta), and IL-10 in the modulation of intercellular adhesion molecule-1 (ICAM-1) expression by macrophages during mycobacterial infection. Clin. Exp. Immunol. 122:335-342.

Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.

Trinchieri, G. 1998. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:83-243.

Tsai, V., G.S. Firestein, W. Arend and N.J. Zvaifler. 1992. Cytokine-induced differentiation of cultured nonadherent macrophages. Cell. Immunol. 144:203-216.

140

References

Tsunawaki, S., M. Sporn, A. Ding and C. Nathan. 1988. Deactivation of macrophages by transforming growth factor-p. Nature (Lond.). 334:260-262.

Tsunawaki, S., M. Sporn and C.F. Nathan. 1989. Comparison of transforming growth factor-beta and a macrophage-deactivating polypeptide from tumor cells. Differences in antigeniCity and mechanism of action. J. Immunol. 142:3462-3468.

Tsung, K., J.B. Meko, G.R. Peplinski, Y.L. Tsung and J.A. Norton. 1997. IL-12 induces T helper !-directed antitumor response. J. Immunol. 158:3359-3365.

Tsutsui, H., K. Nakanishi, K. Matsui, K. Higashino, H. Okamura, Y. Miyazawa and K. Kaneda. 1996. IFN-y-inducing factor up-regulates Fas ligand­mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157:3967-3973.

Unanue, E. R. 1984. Antigen-presenting function of the macrophage. Annu. Rev. Immunol. 2:395-428.

Vadiveloo, P.K. 1999. Macrophages: proliferation, activation and cell cycle proteins. J. Leukoc. Bioi. 66:579-582.

Valledor, A.F., F.E. Borras, M. Culleii-Young and A. Celada. 1998. Transcription factors that regulate monocyte/macrophage differentiation. J. Leukoc. Bioi. 63:405-417.

van de Loosdrecht, A.A., G.J. Ossenkoppele, R.H. Beelen, M.G. Broekhoven, A.M. Drager and M.M. Langenhuijsen. 1993. Apoptosis in .tumor necrosis factor-alpha-dependent, monocyte-mediated leukemic cell death: a functional, morphologic, and flow-cytometric analysis. Exp. Hematol. 21:1628-1639.

van Egmond, M., A.J. Hanneke van Vuuren and J.G. van de Winkel. 1999. The human Fe receptor for IgA (Fe alpha RI, CD89) on transgenic peritoneal macrophages triggers phagocytosis and tumor cell lysis. Immunol. Lett. 68:83-87.

van Furth, R., M.C. Martina, D. Diesselhoff-Den and H. Mattie. 1973. Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. J. Exp. Med. 138:1314-1330.

van Furth, R. 1988. Phagocytic cells: development and distribution of mononuclear phagocytes in normal steady state and inflammation. In Inflammation: Basic Principles and Clinical Correlates, J.I. Gallin, I.M. Goldstein and R Snyderman, eds. Raven Press, New York, USA.

141

References

Van Vugt, E., E.A. Van Rijthoven, E.W. Kamperdijk and R.H. Beelen. 1996. Omental milky spots in the local immune response in the peritoneal cavity of rats. Anat. Rec. 244:235-245.

Viera, L., Y.Z. Ye, A.G. Estevez and J.S. Beckman. 1999. Immunohistochemical methods to detect nitrotyrosine. Methods Enzymol. 301:373-381.

Viner, R.I., D.A. Ferrington, T.D. Williams, T.J. Bigelow and C. Schoneich. 1999. Protein modification during biological aging: selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in skeletal muscle. Biochem. J. 340:657-669.

Viraben, R., P. Brousse and L. Lamani. 1996. Reversible cutaneous lymphoma occurring during methotrexate therapy. Br. J. Dermatol. 130:1-8.

Vodovotz, Y., L. Chesler, H. Chong, S.J. Kim, J.T. Simpson, W. DeGraff, G.W. Cox, A.B. Roberts, D.A. Wink and M.H. Barcellos-Hoff. 1999. Regulation of transforming growth factor-beta1 by nitric oxide. Cancer Res. 59:2142-2149.

Waller, E.K. and M.S. Ernstoff. 2003. Modulation of antitumor immune responses by hematopoietic cytokines. Cancer. 97: 1797-1809.

Weir, D.M. and J. Stewart. 1993. In Immunology. 7th Edition. Churchill Livingstone, Longman Singapore Publishers Ltd.

Weller, M. and A. Fontana. 1995. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege ofthe brain. Brain Research News. 21:128-151.

Wiktor-Jedrzejczak, W. and S. Gordon. 1996. Cytokine regulation of the macrophage system studied using colony stimulating factor-1-deficient op/op mouse. Physiol. Rev. 76:927-947.

Wilkinson, M. and A.G. Morris. 1985. The interaction between interferons and macrophages. In Mononuclear Phagocytes: Physiology and Pathology. R.T. Dean and W. Jessup, eds. Elsevier Science Publishers, Amsterdam.

Willimann, K., D.F. Legler, M. Loetscher, R.S. Roos, M.B. Delgado, I. Clark­Lewis, M. Baggiolini and B. Moser. 1998. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur. J. Immunol. 28:2025-2034.

142

References

Wink, D.A. and J.B. Mitchell. 1998. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic and cytoprotective mechanisms of nitric oxide. Free Rad. Bioi. Med. 25:434-456.

Witworth, P.W., C.C. Pak, J. Esgro, E.S. Kleinerman and I.J. Fidler. 1990. Macrophages and cancer. Cancer Metas. Rev. 4:319-351.

Wu, Q., Y. Wang, J. Wang, E.O. Hedgeman, J.L. Browning and Y.-X. Fu. 1999. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J. Exp. Med. 190:629-638.

Xia, Y. and J.L. Zweier. 1997. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc. Natl. Acad. Sci. USA. 94:6954-6958.

Xie, K., Z. Dong and I.J. Fidler. 1996. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukoc. Bioi. 59:797-803.

Xing, Z., A. Zganiacz and M. Santosuosso. 2000. Role ofiL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-a and nitric oxide from macrophages via IFN-y induction. J. Leukoc. Bioi. 68:897-902.

Yagisawa, M., K. Saeki, E. Okuma, T. Kitamura, S. Kitagawa, H. Hirai, Y. Yazaki, F. Takaku and A. Yuo. 1999. Signal transduction pathways in normal human monocytes stimulated by cytokines and mediators: comparative study with normal human neutrophils or transformed cells and the putative roles in functionality and cell biology. Exp. Hematol. 27:1063-1076.

Yamamura, M., R. Modlin, J.D. Ohmen and R.L. Moy. 1993. Local expression of antinflammatory cytokines in cancer. J. Clin. Invest. 91: 1005-1010.

Yanagihara, S., E. Komura, J. Nagafune, H. Watarai and Y. Yamaguchi. 1998. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol. 161:3096-3102.

Yoneda, Y. and R. Yoshida. 1998. The role ofT cells in allografted tumor rejection: IFN-y released from T cells is essential for induction of effector macrophages in the rejection site. J. Immunol. 160:6012-6017.

Yoshida, R., T. Imai, K. Hieshima, J. Kusuda, M. Baba, M. Kitaura, M. Nishimura, M. Kakizaki, H. Nomiyama and 0. Yoshie. 1997. Molecular cloning of a novel human CC chemokine EBil-ligand chemokine that is a specific functional ligand for EBil, CCR7. J. Bioi. Chern. 272:13803-13809.

143

References

Yoshida, R., M. Nagira, T. Imai, M. Baba, S. Takagi, Y. Tabira, J. Akagi, H. Nomiyama and 0. Yoshie. 1998. EBil-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR 7 and efficiently migrate toward ELC. Int. Immunol. 10:901-910.

Yoshida, R., Y. Yoneda, M. Kuriyama and T. Kubota. 1999. IFN-y and cell-to­cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment. J. Immunol. 163:148-154.

Young, H.A. and K.J. Hardy. 1995. Role of interferon-gamma in immune cell regulation. J. Leukoc. Biol. 58:373-381.

Young, A.J. 1999. The physiology of lymphocyte migration through the single lymph node in vivo. Semin. Immunol. 11:73-83.

Yu, W.G., N. Yamamoto, H. Takenaka, J. Mu, X.G. Tai, J.P. Zou, M. Ogawa, T. Tsutsui, R. Wijesuriya, R. Yoshida, S. Herrmann, H. Fujiwara and T. Hamaoka. 1996. Molecular mechanisms underlying IFN-y-mediated

. tumor growth inhibition induced during tumor immunotherapy with riL-12. Int. Immuno1. 8:855-865.

Zembala, M., M. Siedlar, J. Marcinkiewicz and J. Pryjma. 1994. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur. J. Immunol. 24:435-439.

Zhang, T., K. Kawakami, M.H. Qureshi, H. Okamura, M. Kurimoto and A. Saito. 1997. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma-interferon by natural killer cells. Infect. Immun. 65:3594-3599.

Zhang, Y., Y.Y. Zhang, M. Ogata, P. Chen, A. Harada, S. Hashimoto and K. Matsushima. 1999. Transforming growth factor-beta1 polarizes murine hematopoietic progenitor cells to generate Langerhans cell-like dendritic cells . through a monocyte/macrophage differentiation pathway. Blood. 93:1208-1220:

Zhou, Y., J.A. McEarchern, E. Howard, G. Pestano, M.L. Salgaller and M.L. Bosch. 2003. Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T -cell responses. Cancer Immunol. Immunother. 52:413-422.

Zlotnik, A. and 0. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity. 12:121-127.

144